Bromodomain Containing 9 (BRD9) Peptid
BRD9
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BRD9 Produkte
- BRD9 (Bromodomain Containing 9 (BRD9))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BRD9 antibody (Catalog #: ARP34803_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BRD9 (Bromodomain Containing 9 (BRD9))
- Hintergrund
-
BRD9 is a member of protein family that contains bromodomain. It is potentially related to cancer.
Alias Symbols: PRO9856, LAVS3040
Protein Size: 481 - Molekulargewicht
- 53 kDa
- Gen-ID
- 65980
- NCBI Accession
- NM_001009877, NP_001009877
- UniProt
- Q9H8M2
-
Sie sind hier:
